Treatment of Pseudoarthrosis Using Tissue-Engineered Bone Graft


Article Preview

Subjects were graft patients with pseudoarthrosis (average age, 60.3 years; range, 17-85 years). Pseudoarthrosis affected the thoracolumbar spine, the femur, the clavicle, the humerus and the metatarsal. From the ilium (tibia in one patient), 10-20 ml of bone marrow fluid was collected, and then, it was immediately transferred to the culture room and incubated in a flask containing MEM with 15% autologous or fetal bovine serum, etc.. After 2 weeks in primary culture, cells were released by trypsin treatment and were subsequently incubated with porous beta-TCP in order to prepare tissue-engineered artificial bone, according to the previously reported modified culturing technique. Tissue-engineered artificial bone was grafted around the non-union site of each affected long bone, while tissue-engineered artificial bone was grafted via the pedicle of each affected vertebral body. In all patients, favorable bone formation was seen at three months after surgery. In the patients with pseudoarthrosis of the spine, CT and MRI confirmed favorable vertebral body formation. In the patients with pseudoarthrosis of a long bone, the artificial bone was remodeled and favorable bone union was confirmed. In 2 patients in whom bone biopsy was performed during pin removal, bone regeneration was confirmed histologically. With present type of tissue-engineered artificial bone, an artificial material with a high bone regeneration capacity can be prepared by aspiration, which is minimally invasive, and thus when compared to iliac bone grafts, it is possible to radically reduce postoperative pain without damage of autologous bone.



Key Engineering Materials (Volumes 284-286)

Main Theme:

Edited by:

Panjian Li, Kai Zhang and Clifford W. Colwell, Jr.




T. Yoshikawa et al., "Treatment of Pseudoarthrosis Using Tissue-Engineered Bone Graft", Key Engineering Materials, Vols. 284-286, pp. 1057-1060, 2005

Online since:

April 2005




[1] T. Yoshikawa : Mat. Sci. Eng. C-Biomim. 13(2000), p.29.

[2] C. Maniatopoulos, J. Sodek, and A.H. Melcher: Cell Tissue Res. 254 (1988), p.317.

[3] J.E. Davies, R. Chernecky, B. Lowenberg, et al.: Cells Mater. 1 (1991), p.3.

[4] T. Yoshikawa S.A. Peel, J.R. Gladstone, et al.: Biomed. Mater. Eng. 7 (1997) , p.369.

[5] T. Yoshikawa, H. Ohgushi, Y. Dohi, et al.: Biomed. Mater. Eng. 7 (1997), p.49.

[6] K-L Yao , R. Jr. Todescan and J. Sodek: J. Bone Miner. Res. 9 (1994), p.231.

[7] T. Yoshikawa, H. Ohgushi and S. Tamai: J. Biomed. Mater. Res. 32 (1996), p.481.

[8] T. Yoshikawa, H. Ohgushi, Akahane M, et al.: J. Biomed. Mater. Res. 41(1998), p.568.

[9] T. Yoshikawa, H. Nakajima, E. Yamada, et al.: J. Bone Miner. Res. 15 (2000), p.1147.

[10] T. Yoshikawa, T. Noshi, H. Mitsuno, et al.: Mat. Sci. Eng. C-Biomim., 17 (2001), p.19.

[11] T. Yoshikawa, H. Ohgushi, H. Nakajima, et al.: Transplantation. 69(2000), p.128.

[12] T. Yoshikawa, H. Ohgushi, T. Uemura, et al.: Biomed. Mater. Eng. 8 (1998), p.311.

[13] T. Yoshikawa, H. Ohgushi, Y. Takakura, Tissue Engineering in press.

[14] T. Yoshikawa, J. Iida, Y. Ueda, et al.: J. Biomed. Mater. Res. 67(2003), p.1473.

[15] J. Iida, T. Yoshikawa , M. Akahane, et al.: Cell Transplantation, in press.

[16] S.S. Reuben, P. Vieira, S. Faruqi, et al.: Anesthesiology 95 (2001), p.390.

[17] T. Yoshikawa, J. Iida, Y. Takakura: Bioceramocs Bioceramics 16(2003) p.1063.